Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes
B. Bishal Paudel, Su‐Fern Tan, Todd E. Fox, Johnson Ung, Upendarrao Golla, Jeremy J.P. Shaw, Wendy Dunton, Irene Lee, Wisam A. Fares, Satyam Patel, Arati K. Sharma, Aaron D. Viny, Brian M. Barth, Martin S. Tallman, Myles C. Cabot, , Thomas P. Loughran
This study identifies two sphingolipidomic subtypes in AML, with one subtype associated with poor clinical outcomes and high-risk features.
Blood Advances · Jan 3, 2024Peer-reviewedSystems Biology